The Intraoperative Neuromonitoring IONM Market is expanding as hospitals adopt real-time monitoring to help protect neurological function during complex surgeries. WiseGuyReports estimates the market at USD 1.71 billion in 2024 and projects it to reach USD 2.96 billion by 2032, representing a 7.12% CAGR.
IONM technology is advancing through multimodal monitoring, wireless systems, and AI-assisted analysis. EEG, EMG, motor evoked potentials, and somatosensory evoked potentials can provide surgeons with real-time information about neurological activity during procedures.
The technology is widely used in neurological, spinal, cranial, and peripheral nerve surgeries. Hospitals remain major end users, while clinics and ambulatory surgical centers are also adopting IONM as minimally invasive and outpatient procedures become more common.
North America held the largest market share in 2023, supported by established healthcare infrastructure and high adoption of advanced surgical technologies. Asia-Pacific is expected to experience strong growth as healthcare investment and access to advanced neurological procedures increase.
Future opportunities include portable monitoring platforms, wireless systems, AI-powered signal interpretation, and integration with other surgical technologies. These developments could make IONM more accessible while supporting efficient monitoring during increasingly complex procedures.